scholarly journals False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain

Medicine ◽  
2021 ◽  
Vol 100 (17) ◽  
pp. e25582
Author(s):  
Yu Zeng ◽  
Timothy J. Poterucha ◽  
Andrew J. Einstein ◽  
Qing Zhang ◽  
Yucheng Chen ◽  
...  
2018 ◽  
Vol 151 (2) ◽  
pp. 154-163 ◽  
Author(s):  
Peter P Chen ◽  
Christopher A Tormey ◽  
Stephanie C Eisenbarth ◽  
Richard Torres ◽  
Susan S Richardson ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Temidayo Abe ◽  
Titilope Olanipekun ◽  
Mtanis Khoury ◽  
Obiora Egbuche ◽  
Effoe Valery ◽  
...  

2018 ◽  
Vol 20 (4) ◽  
pp. 486-486
Author(s):  
Olena Nemchyna ◽  
Rolf Gebker ◽  
Felix Schoenrath ◽  
Christoph Knosalla ◽  
Volkmar Falk ◽  
...  

2018 ◽  
Vol 49 (1) ◽  
pp. 9-14
Author(s):  
Monika Adamska ◽  
Anna Komosa ◽  
Tatiana Mularek ◽  
Joanna Rupa-Matysek ◽  
Lidia Gil

AbstractCardiac amyloidosis is a rare and often-misdiagnosed disorder. Among other forms of deposits affecting the heart, immunoglobulin-derived light-chain amyloidosis (AL amyloidosis) is the most serious form of the disease. Delay in diagnosis and treatment may have a major impact on the prognosis and outcomes of patients. This review focuses on the presentation of the disorder and current novel approaches to the diagnosis of cardiac involvement in AL amyloidosis.


Circulation ◽  
2022 ◽  
Vol 145 (1) ◽  
pp. 18-20
Author(s):  
Justin L. Grodin ◽  
Larry D. Anderson ◽  
Ankit Kansagra

2020 ◽  
Vol 26 (10) ◽  
pp. S100
Author(s):  
Bryan E-Xin Tan ◽  
Samarthkumar Thakkar ◽  
Vishal Parikh

2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
R D Adam ◽  
A Jercan ◽  
S Badelita ◽  
D Coriu ◽  
C Stan ◽  
...  

Abstract Background Cardiac amyloidosis (CA) is described as one entity. However, several subtypes of amyloid can infiltrate the heart: light chain (AL) and tranthyretin (ATTR) are the most common. Purpose To characterize the specific findings of the CA subtypes as a tool to aid differential diagnosis between AL and ATTR CA. Material and methods: Consecutive patients with CA were evaluated by clinical examination, ECG, cardiac biomarkers and echocardiography with both conventional and myocardial deformation study of the left ventricle (LV), left atrium (LA) and right ventricle (RV). Amyloid subtype was described using light chain assessment for AL-CA and 99Tc-HMPD scintigraphy and TTR gene sequencing for ATTR-CA. Results 32 patients with CA were included, 13 with ATTR and 19 with AL. Patients in AL group were significantly older, with higher levels of cardiac biomarkers. At similar LV EF and wall thickness, they had lower GLS. LA function parameters were also lower in AL pts (table). Using ROC curves, the best predictors for AL diagnosis were NTproBNP (AUC 0.937) and Tn levels (AUC 0.958), as well as LV GLS and pericardial fluid presence (both AUC 0.750). Conclusions At similar LV wall thickness and ejection fraction, cardiac dysfunction appears to be more severe in AL pts, with lower global LV longitudinal strain, worse LA function, higher sPAP and NTproBNP. ATTR (13 pts) AL (19 pts) p Age (years) 50 ± 12 60 ± 8 0.01 NTproBNP (pg/mL) 3066 ± 3720 11755 ± 9114 0.02 hsTnI (ng/mL) 0.005 ± 0.008 0.147 ± 0.161 0.04 Pericardial fluid (%) 53% 100% 0.002 LVEDV (mL) 88 ± 25 75 ± 38 NS LVMi (g/m2) 166 ± 47 168 ± 41 NS LVEF (%) 50 ± 8 49 ± 16 NS LV GLS (%) -12.1 ± 3.8 -8.9 ± 4.5 0.04 Septal Basal/Apical LS 0.33 ± 0.17 0.25 ± 0.27 NS LAVi (mL/m2) 46 ± 21 45 ± 14 NS LAEF 4CV (%) 35 ± 21 24 ± 8 0.05 LA systolic strain (%) 17.4 ± 11.9 10.5 ± 5.0 0.02 RV free wall thickness (mm) 7.0 ± 1.5 7.6 ± 1.4 NS RV 6-segments strain (%) -15 ± 4 -10 ± 8 0.09 sPAP (mmHg) 36.6 ± 12.0 48.6 ± 17.2 0.04


Sign in / Sign up

Export Citation Format

Share Document